MedPath

Determining the role of Von Willebrand factor and ADAMTS13 in the adhesion of sickled erythrocytes to endothelial cells

Conditions
hereditary anemia
sickle cell disease
10038158
10027664
Registration Number
NL-OMON32743
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Adult sickle cell patients with HbSS or HbS*0 als genotype

Exclusion Criteria

Therapeutic intervention with hydroxyurea (Hydrea), with an extra exclusion criterium for the non-transfused patients that they have not been transfused in the last 4 months.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study parameter is the amount and percentage of adhesion as compared to a<br /><br>baseline measurement with normal erythrocytes. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>-</p><br>
© Copyright 2025. All Rights Reserved by MedPath